Search details
1.
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial.
Lancet
; 401(10371): 105-117, 2023 01 14.
Article
in English
| MEDLINE | ID: mdl-36495879
2.
Trajectories of alcohol consumption during life and the risk of developing breast cancer.
Br J Cancer
; 125(8): 1168-1176, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34483338
3.
Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer.
Breast Cancer Res
; 22(1): 9, 2020 Jan 22.
Article
in English
| MEDLINE | ID: mdl-31969184
4.
NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer.
Breast Cancer Res
; 21(1): 133, 2019 12 03.
Article
in English
| MEDLINE | ID: mdl-31796073
5.
Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study.
Breast Cancer Res Treat
; 174(3): 693-701, 2019 Apr.
Article
in English
| MEDLINE | ID: mdl-30607629
6.
Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2-) early breast cancer (EBC): results from the GEICAM/2006-10 study.
Breast Cancer Res Treat
; 177(1): 115-125, 2019 Aug.
Article
in English
| MEDLINE | ID: mdl-31152327
7.
A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012-12 (EDALINE) study.
Invest New Drugs
; 37(1): 98-108, 2019 02.
Article
in English
| MEDLINE | ID: mdl-29948356
8.
Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis.
Oncologist
; 22(11): 1301-1308, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28701571
9.
Physical activity and breast cancer risk by pathological subtype.
Gynecol Oncol
; 144(3): 577-585, 2017 03.
Article
in English
| MEDLINE | ID: mdl-28057355
10.
Circulating miR-200c and miR-141 and outcomes in patients with breast cancer.
BMC Cancer
; 15: 297, 2015 Apr 02.
Article
in English
| MEDLINE | ID: mdl-25885099
11.
Dual neoadjuvant blockade plus chemotherapy versus monotherapy for the treatment of women with non-metastatic HER2-positive breast cancer: a systematic review and meta-analysis.
Clin Transl Oncol
; 25(4): 941-958, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36417083
12.
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial.
Cancer
; 118(1): 241-7, 2012 Jan 01.
Article
in English
| MEDLINE | ID: mdl-21717449
13.
Type does matter. Use VIRGIN olive oil as your preferred fat to reduce your risk of breast cancer: case-control EpiGEICAM study.
Eur J Clin Nutr
; 76(9): 1343-1346, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35194197
14.
Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors-Health-EpiGEICAM Study.
Cancers (Basel)
; 14(19)2022 Sep 27.
Article
in English
| MEDLINE | ID: mdl-36230628
15.
Results of the implementation of a pharmacogenomics platform based on NGS technologies. Combining clinical and research approaches.
Farm Hosp
; 45(7): 11-37, 2021 12 22.
Article
in English
| MEDLINE | ID: mdl-35379108
16.
Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2-positive breast cancer?
Virchows Arch
; 479(4): 853-857, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-33934230
17.
Serum Phospholipids Fatty Acids and Breast Cancer Risk by Pathological Subtype.
Nutrients
; 12(10)2020 Oct 14.
Article
in English
| MEDLINE | ID: mdl-33066483
18.
Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study.
Sci Rep
; 10(1): 7741, 2020 05 08.
Article
in English
| MEDLINE | ID: mdl-32385335
19.
Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution.
Breast Cancer (Dove Med Press)
; 11: 29-42, 2019.
Article
in English
| MEDLINE | ID: mdl-30643452
20.
Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion.
Eur J Cancer
; 120: 54-64, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31491604